The Kentucky Neuroscience Institute integrates the expertise of UK neurology and neurosurgery physicians and researchers. KNI is a regional referral center dedicated to providing comprehensive care to our patients.
KNI offers patients the benefits of Gamma Knife® therapy. It is one of the most precise, powerful and proven treatments for brain and spinal cord tumors. Gamma Knife therapy does not involve surgery. Instead, it focuses precise beams of radiation directly on a tumor.
Additionally, we are the region's only Level IV Epilepsy Center. Our Epilepsy Monitoring Unit (EMU) is a dedicated six-bed unit with the latest diagnostic monitoring equipment to accurately diagnose the causes of epileptic seizures, allowing physicians to create a more accurate treatment plan. The Kentucky Neuroscience Institute also offers the latest advancements in minimally invasive surgery, such as kyphoplasty and other spine procedures, which allows patients to recover much faster.
Botulinum treatment program »
Cerebrovascular disorders »
Comprehensive epilepsy program »
Headache & pain clinic »
Memory & aging clinic »
Movement disorders program »
Multidisciplinary concussion »
Neurogenetics program »
Neurology program »
Neuroimmunology program »
Neuroinfectious disease program »
Neuromuscular disease program »
Neuro-oncology program »
Neuro-ophthalmology program »
Neuropsychology program »
Neurorehabilitation program »
Neurosurgery program »
Neurotoxicology program »
Pediatric neurology program »
Request an appointment online »
Most commonly, patients are referred through their primary care provider or neurologist.
Kentucky ClinicFirst Floor, Wing C740 S. LimestoneLexington KY 40536-0284
Call 859-323-5661Fax 859-323-1127
Monday - Friday, 8 a.m.- 5 p.m.
(across from Starbucks)
AmenitiesDining, Internet/Wi-Fi, Information desk, Pharmacy services, Wheelchairs
Kentucky Clinic Map (PDF, 616 KB) » Directions to Kentucky Clinic Parking »
UK Albert B. Chandler Hospital |
UK Good Samaritan Hospital |
Morris K. Udall Centers of Excellence »
Sanders-Brown Center on Aging »
VA Medical Center »
UK is first in the U.S. to conduct trial of new
Parkinson’s disease treatment. A
clinical trial being conducted at UK is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment of the disease and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.
UK HealthCare’s Kentucky Neuroscience Institute (KNI) has received the Get With The Guidelines – Stroke Gold-Plus Quality Achievement Award by the American Heart Association/American Stroke Association for maintaining nationally recognized standards for the treatment of stroke patients. Learn more about the
Stroke Gold Plus Quality Achievement Award »
Stroke patients at the Kentucky Neuroscience Institute have access not only to the region's top doctors, but also to the most advanced medical technology. The
stroke center at UK Chandler Hospital was the first in the region to be designated as a
Comprehensive Stroke Center.